Smart diagnosis to capture the Intravenous Immunoglobulin Market, reaching US$ 25,884 Million in 2032

Intravenous immunoglobulin (IVIG) is a blood product made up of antibodies that are extracted from healthy donors. It is used to treat a range of conditions including immune deficiencies, autoimmune diseases, and neurological disorders. IVIG is administered via intravenous infusion, and it works by providing the recipient with a boost of antibodies to help fight off infections and other health issues. The global market for IVIG is expected to experience significant growth in the coming years due to a rising incidence of immune system disorders and an increasing demand for biologic therapies.

Market Overview:

The global intravenous immunoglobulin market is likely to reach a market value of US$ 12,000 Million in 2022 and is expected to accumulate a market value of US$ 25,884 Million by registering a CAGR of 7.9% in the forecast period 2022-2032. Growth of the intravenous immunoglobulin market can be attributed to the fact that it is the only available treatment option for treatment. The market for intravenous immunoglobulin registered a CAGR of 5% in the historical period 2016-2021

Request For Free Sample Report of Intravenous Immunoglobulin (IVIg) Market @ https://www.persistencemarketresearch.com/samples/2830

Key Players:

Biotest AG
Baxter International Inc.
Octapharma AG
LFB Biotechnologies
Grifols SA
CSL Behring
China Biologics Products Inc.
Kedrion Biopharma
BDI Pharma Inc.
Pfizer Inc.

Drivers and Restraints:

The intravenous immunoglobulin market is influenced by various drivers and restraints. On the one hand, the increasing prevalence of immunodeficiency disorders, such as primary immunodeficiency diseases (PIDD), and autoimmune diseases, including multiple sclerosis, and chronic inflammatory demyelinating polyneuropathy (CIDP), are driving the demand for intravenous immunoglobulin products. Moreover, advancements in the production process and the availability of plasma-derived and recombinant immunoglobulin products are boosting the market growth. On the other hand, the high cost of these therapies and their adverse effects, including thrombotic events and renal dysfunction, are restraining the market growth. Additionally, the shortage of plasma supply and stringent regulatory requirements for the manufacturing and distribution of intravenous immunoglobulin products are also affecting the market growth.

For critical insights on this market, request for customization here@ https://www.persistencemarketresearch.com/request-customization/2830

Related Reports:

Biosimulation Market
https://www.persistencemarketresearch.com/market-research/biosimulation-market.asp

Medical Oxygen Systems Market
https://www.persistencemarketresearch.com/market-research/medical-oxygen-systems-market.asp

Pyrogen Testing Market
https://www.persistencemarketresearch.com/market-research/pyrogen-testing-market.asp

Neurosurgery Market
https://www.persistencemarketresearch.com/market-research/neurosurgery-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.